Browsing eNauka
Browsing by Project Roche Holding
Showing results 1 to 8 of 8
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2018 | Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome | Schwartz, GG; ...; Dilić, Mirza; ...; Ristić, Arsen D.   ; ...; Simić, Dragan V. ; Ivanović, Nikola; Davidović, Goran T. ; Tasić, Nebojša M.;
Ašanin, Milika R.
; Stojić, Stevo; Apostolović, Svetlana R. ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Arandjelovic, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V. ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1390); | Article | 21a+M21a+ |
| 2020 | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC | Herbst, Roy S; ...; Andric, Zoran G ; ...; (broj, koautora 22) | Article | 21a+M21a+ |
| 2021 | EPROPA: The European program for routine testing of patients with advanced lung cancer | Passiglia, F; ...; Secen, Nevena M; ...; (broj, koautora 20) | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2016 | Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study | Davies, Andrew J; Mihaljevic, Biljana S ; Mercadal, Santiago; Mihaylov, Georgi; Leppa, Sirpa; Cotting, Denise; Veenstra, Klaas; Zharkov, Artem; Dixon, Mark; Barrett, Martin;
Macdonald, David;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2020 | Pirfenidone Effectiveness in Idiopathic Pulmonary Fibrosis with Different Radiologic Patterns | Vasakova, Martina; Sterclova, Martina; Mogulkoc, Nesrin; Lawandowska, Katerzyna; Mueller, Veronika; Hajkova, Marta; Tekavec-Trkanjec, Jasna; Studnicka, MJ; Jovanovic, Dragana D; Stoeva, NY;
Littnerova, Simona; Dusek, Ladislav;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2020 | Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE). | Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 20) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2020 | Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management | Matucci-Cerinic, Marco; ...; Damjanov, Nemanja S; ...; (broj, koautora 20) | Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2021 | Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC | Jassem, Jacek; ...; Andric, Zoran G ; ...; (broj, koautora 19) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |